These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21318189)

  • 1. Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.
    Sourris KC; Harcourt BE; Penfold SA; Yap FY; Morley AL; Morgan PE; Davies MJ; Baker ST; Jerums G; Forbes JM
    Exp Diabetes Res; 2010; 2010():974681. PubMed ID: 21318189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
    Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
    Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P
    Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE.
    He CJ; Koschinsky T; Buenting C; Vlassara H
    Mol Med; 2001 Mar; 7(3):159-68. PubMed ID: 11471552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
    Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
    Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
    Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
    Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
    Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
    Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
    Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
    Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.
    Yu JY; An XF; Liu JS; Ten SC; Wang X; Zhao Y; Huang S; Gu WJ; Gao F
    Diabetes Res Clin Pract; 2010 Feb; 87(2):157-60. PubMed ID: 19945761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.
    Sourris KC; Forbes JM
    Curr Drug Targets; 2009 Jan; 10(1):42-50. PubMed ID: 19149535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
    Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene.
    Kanková K; Kalousová M; Hertlová M; Krusová D; Olsovský J; Zima T
    Arch Physiol Biochem; 2008 Apr; 114(2):111-9. PubMed ID: 18615900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.
    Thallas-Bonke V; Coughlan MT; Tan AL; Harcourt BE; Morgan PE; Davies MJ; Bach LA; Cooper ME; Forbes JM
    Nephrology (Carlton); 2013 Jan; 18(1):47-56. PubMed ID: 23046363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.
    He CJ; Zheng F; Stitt A; Striker L; Hattori M; Vlassara H
    Kidney Int; 2000 Nov; 58(5):1931-40. PubMed ID: 11044213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE mRNA expression in the diabetic mouse kidney.
    Ziyadeh FN; Cohen MP; Guo J; Jin Y
    Mol Cell Biochem; 1997 May; 170(1-2):147-52. PubMed ID: 9144329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.